Published articles

Published articles 1 records found  Search took 0.02 seconds. 
1.
14 p, 1.9 MB Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate : An Interrupted Time Series Study / Abtahi, Shahab (Utrecht University) ; Pajouheshnia, Romin (Utrecht University) ; Durán, Carlos E. (University Medical Center Utrecht) ; Riera-Arnau, Judit (Hospital Universitari Vall d'Hebron) ; Gamba, Magdalena (Utrecht University) ; Alsina, Ema (University Medical Center Utrecht) ; Hoxhaj, Vjola (University Medical Center Utrecht) ; Andersen, Morten (University of Copenhagen. Department of Drug Design and Pharmacology) ; Bartolini, Claudia (Agenzia Regionale di Sanità della Toscana) ; Kristiansen, Sarah Brøgger (University of Copenhagen. Department of Drug Design and Pharmacology) ; Brown, Jeremy (London School of Hygiene & Tropical Medicine) ; Hallgreen, Christine Erikstrup (University of Copenhagen. Copenhagen Centre for Regulatory Science) ; Garcia-Poza, Patricia (Agencia Espanola de Medicamentos y Productos Sanitarios) ; Gardarsdottir, Helga (UMCU. Department of Clinical Pharmacy) ; Gini, Rosa (Agenzia Regionale di Sanità della Toscana) ; Girardi, Anna (Agenzia Regionale di Sanità della Toscana) ; Holthuis, Emily (PHARMO Institute for Drug Outcomes Research) ; Huerta, Consuelo (Universidad Complutense de Madrid. Departamento de Salud Pública y Materno-Infantil) ; Ibáñez, Luisa (Hospital Universitari Vall d'Hebron) ; Limoncella, Giorgio (Agenzia Regionale di Sanità della Toscana) ; Martín-Pérez, Mar (Agencia Espanola de Medicamentos y Productos Sanitarios) ; Paoletti, Olga (Agenzia Regionale di Sanità della Toscana) ; Roberto, Giuseppe (Agenzia Regionale di Sanità della Toscana) ; Souverein, Patrick (Utrecht University) ; Swart, Karin M. A. (PHARMO Institute for Drug Outcomes Research) ; Wing, Kevin (London School of Hygiene & Tropical Medicine) ; Sturkenboom, Miriam (University Medical Center Utrecht) ; Klungel, Olaf (Utrecht University) ; Universitat Autònoma de Barcelona
Due to established teratogenicity of valproates, the EU risk minimisation measures (RMMs) with a pregnancy prevention programme (PPP) for valproate were updated in March 2018. To investigate the effectiveness of the 2018 EU RMMs on valproate utilisation in five European countries/regions. [...]
2023 - 10.1007/s40264-023-01314-3
Drug Safety, june 2023, p. 1-14  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.